Capula Management LTD Eli Lilly & CO Transaction History

Capula Management LTD

$9.23 Billion
Q3 2024

A detailed history of Capula Management LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Capula Management LTD holds 88,584 shares of LLY stock, worth $68 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares

88,584

Previous 1,400 6227.43%

Holding current value

$68 Million

Previous $1.27 Million 6094.16%

% of portfolio

0.85%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $68.2 Million - $84.8 Million	88,363 Added 39983.26%	88,584 $78.5 Million
Q2 2024 Aug 05, 2024	BUY	$724.87 - $909.04 $160,196 - $200,897	221 New	221 $200,000
Q3 2023 Nov 03, 2023	BUY	$434.7 - $599.3 $269,514 - $371,566	620 New	620 $333,000
Q1 2023 May 10, 2023	SELL	$310.63 - $364.82 $2.08 Million - $2.44 Million	-6,688 Reduced 25.24%	19,806 $6.8 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $8.52 Million - $9.93 Million	26,494 New	26,494 $9.69 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $3.21 Million - $3.77 Million	11,509 New	11,509 $3.73 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $1.9 Million - $2.35 Million	-8,439 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $1.87 Million - $2.3 Million	8,439 New	8,439 $1.95 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $291,832 - $377,790	-1,776 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $231,696 - $306,590	1,776 New	1,776 $300,000
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $1.91 Million - $2.3 Million	-14,024 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $1.53 Million - $1.89 Million	12,824 Added 1068.67%	14,024 $1.95 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $32,076 - $39,729	300 Added 33.33%	1,200 $158,000
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $96,111 - $104,544	900 New	900 $101,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capula Management LTD with notifications on news.

Account

Capula Management LTD Eli Lilly & CO Transaction History